Bangladesh has approved the third phase trial of China's Synovac Biotech vaccine on its citizens. Bangladesh is the country with the highest mass density in South Asia and corona infection is increasing rapidly here.

Synovac was searching for people from outside China to be tried on them. The third phase trial of Synovac in Bangladesh has also been confirmed by a member of a committee on Kovid 19. The International Center for Disease Research Bangladesh has said that its trial will start from next month.

Bangladesh Medical Research Council director Mahmood Jahan told the news agency Reuters, "We have given China in principle permission after reviewing the research protocol. 4,200 people will apply to join the trial and half of them will be vaccinated. The trial will be done in seven Kovid 19 hospitals in Dhaka.

There are currently 204,525 cases of corona in Bangladesh and close to three thousand people have died.

Synovac is also going to trial the third phase in Brazil this week.

(Click here for Android APP of IBTN. You can follow us on facebook and Twitter)

Share This News

About sharing